Form 8-K - Current report:
SEC Accession No. 0000950103-21-005992
Filing Date
2021-04-23
Accepted
2021-04-23 16:01:29
Documents
13
Period of Report
2021-04-21
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp149793_8k.htm   iXBRL 8-K 31300
2 EXHIBIT 10.1 dp149793_ex1001.htm EX-10.1 954090
  Complete submission text file 0000950103-21-005992.txt   1354057

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crl-20210421.xsd EX-101.SCH 3169
4 XBRL LABEL FILE crl-20210421_lab.xml EX-101.LAB 34592
5 XBRL PRESENTATION FILE crl-20210421_pre.xml EX-101.PRE 22700
6 EXTRACTED XBRL INSTANCE DOCUMENT dp149793_8k_htm.xml XML 3506
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 21849670
SIC: 8731 Services-Commercial Physical & Biological Research